| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Growth Equity Opportunities 17, LLC | 12% | $87,362,412 | 24,471,264 | Growth Equity Opportunities 17, LLC | 12 Nov 2025 | |||
| Farallon Capital Partners, L.P. | 9.99% | $58,158,975 | 18,288,986 | Dapice Joshua J. | 31 Dec 2024 | |||
| Bain Capital Life Sciences Fund II, L.P. | 9.99% | $55,969,975 | 17,600,621 | Bain Capital Life Sciences Fund II, L.P. | 25 Mar 2025 | |||
| Flynn James E | 6.74% | $48,441,330 | 13,569,000 | Deerfield Mgmt, L.P. | 30 Oct 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 7.3% | +42% | $45,271,324 | +$13,064,544 | 12,681,043 | +40.6% | Venrock Healthcare Capital Partners III, L.P. | 30 Sep 2025 |
| Nantahala Capital Management, LLC | 5.08% | $31,328,089 | 8,775,375 | Nantahala Capital Management, LLC | 30 Sep 2025 | |||
| BlackRock, Inc. | 4.8% | $29,684,104 | 8,314,875 | BlackRock, Inc. | 30 Sep 2025 | |||
| Frazier Life Sciences Public Fund, L.P. | 3.9% | -38.6% | $16,121,257 | -$11,273,642 | 6,745,296 | -41.2% | Frazier Life Sciences Public Fund, L.P. | 30 Jun 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.2% | $17,431,660 | 5,481,654 | Wellington Management Group LLP | 31 Dec 2024 | |||
| Vestal Point Capital, LP | 2.3% | -66.7% | $14,333,550 | -$24,133,200 | 4,015,000 | -62.7% | Vestal Point Capital, LP | 30 Sep 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 162,997,472 | $581,759,045 | -$17,721,320 | $3.57 | 123 |
| 2025 Q2 | 167,625,869 | $382,185,936 | +$4,604,999 | $2.28 | 121 |
| 2025 Q1 | 165,084,968 | $457,300,361 | +$4,913,528 | $2.77 | 133 |
| 2024 Q4 | 162,865,251 | $500,000,306 | -$4,524,160 | $3.07 | 134 |
| 2024 Q3 | 160,489,937 | $680,419,874 | +$47,632,176 | $4.24 | 124 |
| 2024 Q2 | 148,167,816 | $597,127,886 | +$107,030,245 | $4.03 | 130 |
| 2024 Q1 | 121,071,712 | $602,921,495 | +$11,975,850 | $4.98 | 119 |
| 2023 Q4 | 118,973,088 | $559,183,072 | +$9,052,732 | $4.7 | 97 |
| 2023 Q3 | 116,727,664 | $441,241,214 | +$105,054,525 | $3.78 | 83 |
| 2023 Q2 | 89,090,177 | $284,756,437 | +$19,803,798 | $3.2 | 76 |
| 2023 Q1 | 83,504,156 | $162,832,384 | +$6,962,703 | $1.95 | 67 |
| 2022 Q4 | 79,984,853 | $123,981,605 | +$92,945 | $1.55 | 52 |
| 2022 Q3 | 79,924,185 | $123,886,636 | +$4,248,900 | $1.55 | 47 |
| 2022 Q2 | 77,190,826 | $117,329,451 | +$2,431,393 | $1.52 | 47 |
| 2022 Q1 | 75,835,578 | $99,344,996 | +$1,530,761 | $1.31 | 45 |
| 2021 Q4 | 74,670,485 | $92,591,002 | -$976,827 | $1.24 | 45 |
| 2021 Q3 | 75,014,959 | $103,530,069 | -$1,889,497 | $1.38 | 54 |
| 2021 Q2 | 76,209,813 | $129,561,285 | +$1,307,097 | $1.7 | 69 |
| 2021 Q1 | 75,191,392 | $156,437,847 | +$111,831,290 | $2.08 | 77 |
| 2020 Q4 | 21,657,964 | $24,908,582 | -$596,543 | $1.15 | 61 |
| 2020 Q3 | 17,084,936 | $18,623,392 | -$4,005,800 | $1.09 | 62 |
| 2020 Q2 | 19,585,868 | $48,753,921 | +$1,741,034 | $2.49 | 68 |
| 2020 Q1 | 18,855,821 | $39,855,026 | +$5,880,157 | $2.12 | 66 |
| 2019 Q4 | 20,751,617 | $92,685,951 | +$30,690,713 | $4.48 | 73 |
| 2019 Q3 | 15,182,212 | $40,233,563 | -$4,106,411 | $2.65 | 68 |
| 2019 Q2 | 16,990,991 | $40,327,803 | -$12,805,494 | $2.37 | 73 |
| 2019 Q1 | 16,380,544 | $120,724,460 | -$5,355,801 | $7.37 | 79 |
| 2018 Q4 | 17,105,808 | $129,490,149 | -$12,381,610 | $7.57 | 74 |
| 2018 Q3 | 17,983,685 | $200,696,346 | +$36,314,360 | $11.16 | 78 |
| 2018 Q2 | 14,712,320 | $166,549,936 | +$22,144,237 | $11.32 | 73 |
| 2018 Q1 | 12,952,732 | $119,160,226 | +$8,218,669 | $9.2 | 57 |
| 2017 Q4 | 11,673,132 | $173,228,000 | +$108,421,524 | $14.84 | 47 |
| 2017 Q3 | 4,417,956 | $41,504,000 | +$5,010,883 | $9.35 | 16 |
| 2017 Q2 | 3,979,135 | $23,397,000 | +$23,397,000 | $5.88 | 16 |
| 2016 Q2 | 0 | $0 | -$1,000 | 0 | |
| 2016 Q1 | 142 | $1,000 | $7.04 | 1 |